Project Number 5R44AG056231-02 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Glycosaminoglycan-Interacting Small Molecule (GISMO) as Alzheimers Therapeutics Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator GREGOR, PAUL Principal Investigator First Name PAUL Principal Investigator Last Name GREGOR Awardee Organization GISMO THERAPEUTICS, INC. Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development FY Overall Cost $952,480 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
